Activity value 65vietnam Buyer&Supplier,Last transaction date:
2025-04-23
Overview
Import data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for vcp pharmaceutical joint stock co from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 1 transactions, with a transaction quantity of 3 and a transaction weight of 0.
Product description
Drug Production Mixture of Ertapenem sodium and sodium bicarbonate and sodium hydroxide with ratio (809.6:135,4:55); Lot number: 805028AA044; NSX: August 3, 2024; HSD: August 2, 2026, TC: NSX. NSX: Savior Lifetec Corporation-Taiwan.
Expand
Trade date
2024/08/20
B/L No.
310724stl24047361
Suppliers
china national pharmaceutical foreign trade corp.
Buyers
vcp pharmaceutical joint stock co
Product description
Raw materials for the production of antibiotics Ampicillin Sodium and Sulbactam Sodium Ratio 2:1 Sterile; 2 lots: 524071201, Manufacturing date: 12/7/2024 and 524071103, Manufacturing date: 11/7/2024, Expiry date: 6/2026. Standard: manufacturer. 100% new
Expand
Trade date
2024/08/19
B/L No.
——
Suppliers
china national pharmaceutical foreign trade corp.
Buyers
vcp pharmaceutical joint stock co
Product description
NLSX K/S Ampicillin Sodium and Sulbactam Sodium Ratio 2:1 Sterile; Lot: 524071202; Manufacturer: July 12, 2024, Expiry date: June 2026, TC: Manufacturer; Manufacturer: North China Pharmaceutical Group Semisyntech Co., Ltd
Expand
Trade date
2024/08/13
B/L No.
——
Suppliers
china national pharmaceutical foreign trade corp.
Buyers
vcp pharmaceutical joint stock co
vcp pharmaceutical joint stock co is vietnam Buyer&Supplier,
and primarily engages in the import and export business of products such as ceftriaxone sodium,entercavir,neomycin sulphate.
According to the 52wmb.com global trade database, as of 2025-04-23, the company has completed 767 international trades,
with its main trading regions covering china,india,taiwan etc.
The core products include HS29419000,HS70109040,HS39233090 etc,
often transported via noi bai airport vn,port cang lach huyen hp vn, port hanoi noibai etc,
and its main trading partners are china national pharmaceutical foreign trade corp.,ennovpha industries asia ltd.,albios lifesciences pvt ltd..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on vcp pharmaceutical joint stock co is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.